Bril F - Search Results

1

Researchers call for more flexible editorial conduct rather than abruptly adopting only the new MASLD nomenclature.

Lonardo A, Bril F, Caldwell SH, Eslam M, Fan JG, Gish RG, Gronbaek H, Sanal MG, Stefan N, Suzuki A, Targher G, Tilg H, Yu ML, Zheng MH, George J. Lonardo A, et al. Among authors: bril f. J Hepatol. 2024 May;80(5):e192-e194. doi: 10.1016/j.jhep.2024.01.012. Epub 2024 Feb 9. J Hepatol. 2024. PMID: 38336589 No abstract available.

2

Endpoints in NASH Clinical Trials: Are We Blind in One Eye?

Lonardo A, Ballestri S, Mantovani A, Targher G, Bril F. Lonardo A, et al. Among authors: bril f. Metabolites. 2024 Jan 8;14(1):40. doi: 10.3390/metabo14010040. Metabolites. 2024. PMID: 38248843 Free PMC article. Review.

3

Noninvasive tests to identify liver fibrosis in metabolic dysfunction-associated steatotic liver disease are affected by race.

Bril F, Gray M. Bril F, et al. Obesity (Silver Spring). 2024 Mar;32(3):612-622. doi: 10.1002/oby.23960. Epub 2023 Dec 27. Obesity (Silver Spring). 2024. PMID: 38151987

4

Adipose Tissue Dysfunction in Polycystic Ovary Syndrome.

Bril F, Ezeh U, Amiri M, Hatoum S, Pace L, Chen YH, Bertrand F, Gower B, Azziz R. Bril F, et al. J Clin Endocrinol Metab. 2023 Dec 21;109(1):10-24. doi: 10.1210/clinem/dgad356. J Clin Endocrinol Metab. 2023. PMID: 37329216

5

Metabolic Syndrome and Its Association with Nonalcoholic Steatohepatitis.

Bril F, Sanyal A, Cusi K. Bril F, et al. Clin Liver Dis. 2023 May;27(2):187-210. doi: 10.1016/j.cld.2023.01.002. Epub 2023 Feb 26. Clin Liver Dis. 2023. PMID: 37024202 Review.

6

Semaglutide in NASH-related cirrhosis: too late to the party?

Bril F. Bril F. Lancet Gastroenterol Hepatol. 2023 Jun;8(6):494-495. doi: 10.1016/S2468-1253(23)00069-9. Epub 2023 Mar 16. Lancet Gastroenterol Hepatol. 2023. PMID: 36934739 No abstract available.

7

Hypercholesterolemia After COVID-19: Time to Include Lipoprotein X Among the Differential Diagnoses.

Girard J, Wagner C, Ravi S, Agarwal M, Bril F. Girard J, et al. Among authors: bril f. AACE Clin Case Rep. 2023 Mar-Apr;9(2):35-38. doi: 10.1016/j.aace.2023.01.001. Epub 2023 Jan 7. AACE Clin Case Rep. 2023. PMID: 36643829 Free PMC article.

8

Pioglitazone discontinuation in patients with nonalcoholic steatohepatitis is associated with disease recurrence.

Bril F, Kalavalapalli S, Lomonaco R, Cusi K. Bril F, et al. Diabetes Obes Metab. 2023 Apr;25(4):1112-1116. doi: 10.1111/dom.14936. Epub 2022 Dec 22. Diabetes Obes Metab. 2023. PMID: 36495442 No abstract available.

9

Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLD.

Kalavalapalli S, Leiva EG, Lomonaco R, Chi X, Shrestha S, Dillard R, Budd J, Romero JP, Li C, Bril F, Samraj G, Pennington J, Townsend P, Orlando F, Shetty S, Mansour L, Silva-Sombra LR, Bedossa P, Malaty J, Barb D, Gurka MJ, Cusi K. Kalavalapalli S, et al. Among authors: bril f. J Clin Endocrinol Metab. 2023 Apr 13;108(5):1192-1201. doi: 10.1210/clinem/dgac660. J Clin Endocrinol Metab. 2023. PMID: 36378995

10

Differences in HDL-Bound Apolipoproteins in Patients With Advanced Liver Fibrosis Due to Nonalcoholic Fatty Liver Disease.

Bril F, Pearce RW, Collier TS, McPhaul MJ. Bril F, et al. J Clin Endocrinol Metab. 2022 Dec 17;108(1):42-51. doi: 10.1210/clinem/dgac565. J Clin Endocrinol Metab. 2022. PMID: 36173828 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page